In Silico Design of Dual Estrogen Receptor and Hsp90 Inhibitors for ER-Positive Breast Cancer Through a Mixed Ligand/Structure-Based Approach
Molecules · 2024
DOI: 10.3390/molecules29246040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Gabriele La Monica und 5 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche "STEBICEF", University of Palermo, Viale delle Scienze, Ed. 17, 90128 Palerm…. Hauptthemen laut MEDLINE: HSP90 Heat-Shock Proteins, Breast Neoplasms, Molecular Docking Simulation, Receptors, Estrogen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: SAMOTHRACE" (MUR, PNRR-M4C2, ECS_00000022), SPOKE 3-Università degli Studi di Palermo S2-COMMs-Micro and Nanotechnologies for Smart & Sustainable Communities, SiciliAn MicronanOTecH Research and Innovation Center “SAMOTHRACE”, SPOKE 3—Università degli Studi di Palermo S2-COMMs—Micro and Nanotechnologies for Smart & Sustainable Communities and National Biodiversity Future Center (….
Abstract (Originalsprache)
Breast cancer remains one of the most prevalent and lethal malignancies in women, particularly the estrogen receptor-positive (ER+) subtype, which accounts for approximately 70% of cases. Traditional endocrine therapies, including aromatase inhibitors, selective estrogen receptor degraders/antagonists (SERDs), and selective estrogen receptor modulators (SERMs), have improved outcomes for metastatic ER+ breast cancer. However, resistance to these agents presents a significant challenge. This study explores a novel therapeutic strategy involving the simultaneous inhibition of the estrogen receptor (ER) and the chaperone protein Hsp90, which is crucial for the stabilization of various oncoproteins, including ER itself. We employed a hybrid, hierarchical in silico virtual screening approach to identify new dual ER/Hsp90 inhibitors, utilizing the Biotarget Predictor Tool (BPT) for efficient multitarget screening of a large compound library. Subsequent structure-based studies, including molecular docking analyses, were conducted to further evaluate the interaction of the top candidates with both ER and Hsp90. Supporting this, molecular dynamics simulations demonstrate the high stability of the multitarget inhibitor 755435 in complex with ER and Hsp90. Our findings suggest that several small molecules, particularly compound 755435, exhibit promising potential as dual inhibitors, representing a new avenue to overcome resistance in ER+ breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche "STEBICEF", University of Palermo, Viale delle Scienze, Ed. 17, 90128 Palermo, Italy.
- Istituto per lo Studio dei Materiali Nanostrutturati, Consiglio Nazionale delle Ricerche (CNR), 90128 Palermo, Italy.
- NBFC-National Biodiversity Future Center, Piazza Marina 61, 90133 Palermo, Italy.
ORCID-Profile: Gabriele La Monica, Federica Alamia, Alessia Bono, Francesco Mingoia, Annamaria Martorana, Antonino Lauria
Förderung
- SAMOTHRACE" (MUR, PNRR-M4C2, ECS_00000022), SPOKE 3-Università degli Studi di Palermo S2-COMMs-Micro and Nanotechnologies for Smart & Sustainable Communities
- SiciliAn MicronanOTecH Research and Innovation Center “SAMOTHRACE”
- SPOKE 3—Università degli Studi di Palermo S2-COMMs—Micro and Nanotechnologies for Smart & Sustainable Communities and National Biodiversity Future Center (…
Zitieren
APA
La Monica, G., Alamia, F., Bono, A., Mingoia, F., Martorana, A., & Lauria, A. (2024). In Silico Design of Dual Estrogen Receptor and Hsp90 Inhibitors for ER-Positive Breast Cancer Through a Mixed Ligand/Structure-Based Approach. Molecules. https://doi.org/10.3390/molecules29246040
Vancouver
La Monica G, Alamia F, Bono A, Mingoia F, Martorana A, Lauria A. In Silico Design of Dual Estrogen Receptor and Hsp90 Inhibitors for ER-Positive Breast Cancer Through a Mixed Ligand/Structure-Based Approach. Molecules. 2024. doi:10.3390/molecules29246040
BibTeX
@article{LaMonica2024,
author = {La Monica, Gabriele and Alamia, Federica and Bono, Alessia and Mingoia, Francesco and Martorana, Annamaria and Lauria, Antonino},
title = {In Silico Design of Dual Estrogen Receptor and Hsp90 Inhibitors for ER-Positive Breast Cancer Through a Mixed Ligand/Structure-Based Approach},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29246040}
}
EUVIMED